To evaluate the necessity of routine monitoring in asymptomatic patients with normal baseline hemodynamic and biochemical profiles receiving low-dose oral minoxidil for hair loss, specifically focusing on blood pressure, heart rate, weight, renal and liver function.
Key Findings:
Routine monitoring may not be necessary for asymptomatic patients with normal baseline values, but adverse events were reported in 46% of patients, with hypertrichosis being the most common.
Mean blood pressure, heart rate, weight, and renal/liver function remained stable throughout treatment.
Interpretation:
The study suggests that asymptomatic patients on low-dose oral minoxidil may not require routine monitoring, while those with renal impairment or cardiovascular history should be monitored closely to mitigate risks.
Limitations:
Retrospective, single-center design with a small, all-female sample, which may limit generalizability.
Absence of a comparator group and reliance on graphical exploration without adjusted analyses, potentially affecting the robustness of findings.
Comorbidities and coexisting medications were not accounted for, which may influence adverse effects.
Conclusion:
Monitoring should be individualized; asymptomatic patients with normal baseline profiles may not need routine checks, while those with preexisting conditions should be monitored regularly to ensure safety.
A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness
